Author:
Alabi Rasheed Omobolaji,Sjöblom Anni,Carpén Timo,Elmusrati Mohammed,Leivo Ilmo,Almangush Alhadi,Mäkitie Antti A.
Funder
Helsingin ja Uudenmaan Sairaanhoitopiiri
Sigrid Juséliuksen Säätiö
Reference80 articles.
1. V. Lorenzoni, A.K. Chaturvedi, J. Vignat, M. Laversanne, F. Bray, S. Vaccarella, The current burden of oropharyngeal cancer: a global assessment based on GLOBOCAN 2020, Cancer Epidemiol. Biomark. Prevent. 31 (2022) 2054–2062. .
2. Tumor-Associated Trypsin Inhibitor (TATI) as a biomarker of poor prognosis in oropharyngeal squamous cell carcinoma irrespective of HPV status;Sjöblom;Cancers,2021
3. An interpretable machine learning prognostic system for risk stratification in oropharyngeal cancer;Alabi;Int. J. Med. Inf.,2022
4. MR imaging of oral cavity and oropharyngeal cancer;Abdel Razek;Magn. Reson. Imaging Clin. N. Am.,2022
5. Oropharyngeal cancer incidence and mortality trends in all 50 States in the US, 2001–2017;Damgacioglu;JAMA Otolaryngol. Head Neck Surg.,2022
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献